Abstract P2-12-04: Impact of Weight and Weight Variation in Adolescent and Young Adult (AYA) Women with Invasive Breast Cancer
Background: Breast cancer (BC) is the most common malignancy in adolescent and young adult (AYA) women age 15-39, and the incidence continues to rise each year (1, 2). The reason for this remains unknown, but one potential etiology includes the increasing incidence of obesity (1). Studies in premenopausal women have demonstrated that a high body mass index (BMI) prior to BC diagnosis is associated with worse clinical outcomes (3). The prognostic value of weight gain after BC diagnosis remains unclear (4) as its impact on recurrence risk and overall survival has been inconsistently reported, with limited data among the AYA population (5). Our aim was to describe the clinical-pathological characteristics of AYA women diagnosed with BC, its association with weight change, and the impact of weight variation during the initial treatment period on patient outcomes. Methods: This retrospective study included patients with invasive stage I-III BC, age 15-39 at the time of diagnosis, that received treatment at the Cleveland Clinic between 1996 and 2023. Data was collected via computerized data extraction and manual chart review. The analysis was limited to patients who had both a pre-diagnosis (within 1.5 years (y) before diagnosis) and post-diagnosis (up to 1.5y after diagnosis) BMI measurement so that change in BMI could be calculated. A BMI reduction of ≥2 units was considered clinically meaningful weight loss and a BMI increase of ≥2 units was considered clinically meaningful weight gain. A change in BMI < 2 units was considered no change or stable weight. Continuous and categorical variables were summarized using median IQR and N (%), respectively. The Kruskal-Wallis test was used to test for differences according to BMI change categories in continuous variables, and either Fisher’s exact test or the Chi-squared test was used to test for differences according to BMI change in categorical variables, as appropriate. The Kaplan-Meier method was used to estimate 5y overall survival (OS) probability, the log-rank test was used to test for differences according to weight change and hazard ratios (HR) were estimated using univariable Cox regression. Results: A total of 345 patients were identified for analysis. 339 patients (98%) were ≥25 years, 5 were age 19-24, and one was ≤18 years. The median pre-diagnosis BMI was 25 kg/m2 (22,31). Stable weight was observed in 242 patients (70%), 52 (15%) experienced weight loss, and 52 (15%) had weight gain during the first 1.5y of treatment from the time of diagnosis. While the measurement and analysis of weight changes focused on the initial BC treatment period, median follow-up time among survivors was 6.8y. During follow-up, 51 patients died from any cause. The 5y OS probability of patients with weight gain, weight loss, and stable weight were 66%, 85%, and 90%, respectively (log-rank P=0.006). Patients with weight gain had a statistically significant increased hazard of mortality as compared to those with no change and with weight loss combined, HR 2.71 (95% CI: 1.44-5.10), P=0.005 Discussion: Overall survival probability was reduced in AYA women with early stage BC that experienced weight gain during the initial treatment period. Approximately 70% of patients had no significant change in BMI during their initial BC treatment course, despite undergoing loco-regional and systemic therapies. These results support counselling AYA women regarding the risk of reduced survival associated with weight gain during the initial BC treatment period. Future research is necessary to examine the impact of longer-term weight changes on the risk of BC recurrence and mortality. Citation Format: Nerea Lopetegui-Lia, Emily C. Zabor, Kenda Alkwatli, Ahmed Mohamed, Hassan Elmaleh, Alex Milinovich, Anukriti Sharma, Blaine Martyn-Dow, Kevin M Pantalone, Daniel Rotroff, Halle CF Moore. Impact of Weight and Weight Variation in Adolescent and Young Adult (AYA) Women with Invasive Breast Cancer [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2024; 2024 Dec 10-13; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(12 Suppl):Abstract nr P2-12-04.
Read more